| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/02/2009 | US7541428 Tumor antigen protein SART-3 and tumor antigen peptides thereof |
| 06/02/2009 | US7541335 Nogo-receptors and methods of use |
| 06/02/2009 | US7541157 Drug screening; amplification free; antihypertensive agent; tissue distribution of radioactivity of the molecules administered is analysed in vivo using suitable imaging devices so no killing of animal is necessary |
| 06/02/2009 | US7541035 Immunogenic peptides for the treatment of prostate and breast cancer |
| 05/28/2009 | WO2009065857A2 Compositions for reducing oxidative stress and uses thereof |
| 05/28/2009 | WO2009065217A1 Novel immunoregulatory peptides, compositions and uses thereof |
| 05/28/2009 | WO2007047834A3 Oral peptide conjugates for metabolic diseases |
| 05/28/2009 | US20090137835 Processes for intermediates for macrocyclic compounds |
| 05/28/2009 | US20090137817 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/28/2009 | US20090137495 Organic Compounds and Their Uses |
| 05/28/2009 | US20090137489 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137488 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137464 Therapeutic fibrin-derived peptides and uses thereof |
| 05/28/2009 | US20090137458 Methods and compositions for increasing skin remodeling |
| 05/28/2009 | US20090136980 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
| 05/28/2009 | CA2703891A1 Compositions for reducing oxidative stress and uses thereof |
| 05/27/2009 | EP2061512A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 05/27/2009 | EP2061503A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 05/27/2009 | EP1740173A4 Azabicyclo-octane inhibitors of iap |
| 05/27/2009 | EP1037651B1 Small peptides and methods for treatment of asthma and inflammation |
| 05/27/2009 | CN101443350A Macrocyclic compounds as antiviral agents |
| 05/27/2009 | CN101443349A Compounds and compositions as channel activating protease inhibitors |
| 05/27/2009 | CN101443348A Compounds and compositions as channel activating protease inhibitors |
| 05/27/2009 | CN101443031A New application of treatment peptides |
| 05/27/2009 | CN101440365A Method for constructing cold-stress resistant Bacterium lacticum gene engineering strain |
| 05/27/2009 | CN101440124A Methods for preventing mitochondrial permeability transition |
| 05/27/2009 | CN101440123A Novel process for synthesizing tetrapeptide (TFA-GLy-Pro-Thr-Ala-OH) |
| 05/27/2009 | CN101440122A Novel process for synthesizing dipeptide (TFA Thr-Ala-OH) |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/26/2009 | US7538245 Process for the manufacture of an enantiopure compound |
| 05/26/2009 | US7538183 HPV vaccine comprising peptides from host cell proteins |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7538085 Macrocyclic peptide antibiotics; drug resistant, drug sensitive bacterial infections |
| 05/26/2009 | US7538083 Compositions and methods for the potentiation of immune responses against target antigens |
| 05/26/2009 | CA2334773C Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009062999A1 Improved ramipril synthesis |
| 05/21/2009 | US20090131331 Novel Nutraceutical Compositions |
| 05/21/2009 | US20090131330 Par-2 agonist |
| 05/21/2009 | US20090131328 Furin inhibitors |
| 05/21/2009 | US20090131326 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090131324 Abuse-resistant amphetamine prodrugs |
| 05/21/2009 | US20090130708 Dipeptide crystals and process for production thereof |
| 05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/20/2009 | EP2060585A2 Gene regulatory peptides |
| 05/20/2009 | EP1562620B1 Modified cytokines for use in cancer therapy |
| 05/20/2009 | CN101434646A Amphiprotic compound and use thereof |
| 05/20/2009 | CN101434645A Synthetic oligopeptide and uses thereof |
| 05/20/2009 | CN100489114C Low-cost production for peptides |
| 05/19/2009 | US7534896 Process for the synthesis of perindopril and its pharmaceutically acceptable salts |
| 05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 05/19/2009 | US7534859 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 05/19/2009 | US7534857 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 05/19/2009 | CA2323237C Improved radiation therapy methods |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/14/2009 | WO2009039361A3 Process for the preparation of (s)-2-(3-tert-butylureido)-3,3-dimethylbutanoic acid |
| 05/14/2009 | WO2007022248A3 Methods of detection of cancer using peptide profiles |
| 05/14/2009 | WO2005113823A3 Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same |
| 05/14/2009 | US20090124809 Process for preparing acyclic hcv protease inhibitors |
| 05/14/2009 | US20090124808 Process for preparing acyclic hcv protease inhibitors |
| 05/14/2009 | US20090124560 Composition Containing Peptide as Active Ingredient |
| 05/14/2009 | US20090124008 Peptides for use in culture media |
| 05/14/2009 | US20090123553 Peptide nanostructures and methods of generating and using the same |
| 05/14/2009 | US20090123531 Glutathione-based delivery system |
| 05/14/2009 | US20090121709 Peptide nanostructures encapsulating A foreign material and method of manufacturing same |
| 05/14/2009 | DE60226243T2 Peptid-bildendes Enzymgen, Pepid-bildendes Enzym und Dipeptidherstellungsverfahren Peptide-forming enzyme gene PEPID-forming enzyme and Dipeptidherstellungsverfahren |
| 05/14/2009 | DE19638870B4 Tubulysine, Verfahren zu ihrer Gewinnung und sie enthaltende Mittel Tubulysins, process for their production and to compositions comprising |
| 05/13/2009 | EP2058328A1 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/13/2009 | EP2058275A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | CN101432295A Peptide |
| 05/13/2009 | CN101429232A Hcv protease inhibitors |
| 05/13/2009 | CN101429231A Antihypertensive active kyrine, preparation and uses thereof |
| 05/13/2009 | CN101429230A Refining method for Ganguertai |
| 05/13/2009 | CN101429229A Method for producing high-purity glutathione |
| 05/13/2009 | CN101429228A Method for extracting and separating glutathione from glutathione fermentation liquor |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/13/2009 | CN100486990C Glutathione calcium chelate and its preparing method, use and composition |
| 05/12/2009 | US7531628 Canine CD20 compositions |
| 05/12/2009 | US7531621 Of the formula, [Cha7,11, des-Met8, Nle18, Tyr34]hPTH(1-34)NH2; disorders of the central nervous system, metabolism, pancreas, and hypothalmus; irregular blood pressure, male infertility; agonists or antagonists |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531509 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 05/12/2009 | CA2253997C Phosphonic acid-substituted benzazepinone-n-acetic acid derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| 05/07/2009 | WO2009058856A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 05/07/2009 | WO2009058244A1 Protective skin care tetrapeptides |
| 05/07/2009 | WO2009057982A1 Composition and method for preventing and treating immune-related disorder |
| 05/07/2009 | WO2008124148A3 Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease |
| 05/07/2009 | WO2006113898A3 Pif tetrapeptides |
| 05/07/2009 | US20090118467 Macromolecular Compounds Having Controlled Stoichiometry |
| 05/07/2009 | US20090118174 Novel peptides and methods for the treatment of inflammatory disorders |
| 05/07/2009 | CA2701787A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 05/07/2009 | CA2701420A1 Protective skin care tetrapeptides |
| 05/06/2009 | EP2054429A2 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 05/06/2009 | EP2054380A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/06/2009 | EP1781686B1 Vla-4 antagonists |
| 05/06/2009 | EP1474439B1 Dipeptides and tripeptides with anti-inflammatory activity |
| 05/06/2009 | EP0742824B1 Wd-40-derived peptides and uses thereof |